Q2 Revenue Estimate Plunges to $350K from $50M a Year Ago
WHWK has more than doubled off its 52-week low of $1.57.
Summary
Whitehawk's Q2 revenue estimate has collapsed to just $350K, down from a $50M estimate in the year-ago quarter. The company is expected to report a loss of $0.30 per share, slightly narrower than the prior quarter's $0.32 loss. This follows a $87.5M private placement in May and an expanded ADC pipeline deal. The dramatic revenue drop raises questions about the commercial trajectory of its existing products. Earnings are due August 12.
At the time of this announcement, WHWK was trading at $4.02 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $222.7M. The 52-week trading range was $1.57 to $5.50. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.